Although the genotype–phenotype connection of WAS/XLT has not been fully clarified, several studies have revealed that the clinical phenotype of typical WAS or milder XLT is potentially influenced by the effects of these mutations and WASp expression [11, 14, 15]. The gene discussed is WAS; the disease is Wiskott-Aldrich syndrome.